与脓毒症相关的蛋白分子很多，包括细胞因子、化学增活素、黏附调节子、可溶性受体、急性期蛋白。
The catalog of proteic molecules associated with sepsis is extensive and includes cytokines, chemokines, adhesion mediators, soluble receptors, and acute-phase proteins.
目的了解血清可溶性肿瘤坏死因子受体(STNFR)1,2与胰岛素抵抗(IR)的关系。
Objective to study the relationship between soluble tumor necrosis factor receptor (STNFR) 1, 2 and insulin resistance (IR).
目的：探讨可溶性肿瘤坏死因子受体在消化道恶性肿瘤患者中的临床意义。
Objective to probe into the clinical significance of serum soluble tumor necrosis factor receptors in patients with malignant carcinoma of digestive system.
可溶性肿瘤坏死因子型受体在斑秃发病中的作用。
Role of Soluble Tumor Necrosis Factor Receptor Type I in Alopecia Areata.
目的：探讨可溶性转铁蛋白受体、血清中铁蛋白在缺铁性贫血诊断中的意义。
Objective:To study the significance of serum ferritin , transferrin receptor in the diagnostic of iron deficient anemia.
第1个模型是通过注射了血管内皮生长因子的抗体，或者可溶性的血管内皮生长因子受体1，从而获得的。
The first model is generated by injection of antibodies to vascular endothelial growth factor or soluble vascular endothelial growth factor receptor 1.
目的探讨脑脊液中可溶性白细胞介素2受体水平的变化对脑膜炎的鉴别诊断价值。
Objective To study differential diagnostic value of soluble interleukin 2 receptor (sIL2R) in cerebrospinal fluid (CSF) to the child patients with intracranial infection.
第一部分阐述了人胰岛素受体配基结合结构域L1和L2的可溶性表达并鉴定了它们的配基结合能力。
The first part of the thesis describes the expression and characterization of the human insulin receptor's ligand-binding domains L1 and L2.
检测了72例肾移植患者血中可溶性白细胞介素2受体（SIL-2R）、肿瘤坏死因子（TNF）及白细胞介素6（IL-6）的水平。
The levels of soluble interlukin- 2 receptor (SIL-2R), tumor necrosis factor (TNF) , and interlukin- 6 (IL-6) were measured in 72 renal allograft recipients.
目的：观察扩张型心肌病患者经过高位硬膜外阻滞术治疗后白细胞介素6及可溶性白细胞介素2受体的变化。
OBJECTIVE To observe the changes of interleukin-6 and soluble interleukin-2 receptor in patients with dilated cardiomyopathy after high epidural anesthesia treatment.
目的探讨了血清可溶性白细胞介素-2受体（SIL-2R）和半胱氨酰白三烯（LTS）水平在支气管肺炎患儿治疗前后的变化及意义。
Objective To investigate the significance of changes of serum SIL-2R and cysteine LTS levels after treatment in pediatric patients with bronchopneumonia.
本发明公开了一种可溶性VEGFR双功能融合受体、其制备方法及其在 制备抗肿瘤药物中的应用。
The invention discloses soluble VEGFR difunctional fusion receptors, a preparation method thereof and the application thereof to antineoplastic preparation.
目的 ：观察中药组 （平哮合剂 ）、氨茶碱组治疗前后患者肺通气功能、临床症状改善及可溶性白细胞介素2受体 （SIL 2R）的变化。
Objective:To observe the changes of pulmonary ventilation capacity, clinic symptoms and the soluble interleukin 2 receptor(SIL 2R) of Pingxiao mixture treated group and aminophylline treated group.
目的 ：观察中药组 （平哮合剂 ）、氨茶碱组治疗前后患者肺通气功能、临床症状改善及可溶性白细胞介素2受体 （SIL 2R）的变化。
Objective:To observe the changes of pulmonary ventilation capacity, clinic symptoms and the soluble interleukin 2 receptor(SIL 2R) of Pingxiao mixture treated group and aminophylline treated group.
应用推荐